Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. 64490-92-2
2. Sodium Tolmetin Dihydrate
3. Tolumetin Sodium Dihydrate
4. Tolmetin (sodium Dihydrate)
5. Tolmetin Sodium Salt Dihydrate
6. Sodium;2-[1-methyl-5-(4-methylbenzoyl)pyrrol-2-yl]acetate;dihydrate
7. Sodium 1-methyl-5-p-toluoylpyrrole-2-acetate Dihydrate
8. 02n1tzf99f
9. Chebi:72014
10. Ncgc00017129-01
11. Cas-64490-92-2
12. 1h-pyrrole-2-acetic Acid, 1-methyl-5-(4-methylbenzoyl)-, Sodium Salt, Dihydrate
13. Dsstox_cid_25594
14. Dsstox_rid_80987
15. Dsstox_gsid_45594
16. Mcn-2559-21-98
17. Nsc-757341
18. Sodium 2-(1-methyl-5-(4-methylbenzoyl)-1h-pyrrol-2-yl)acetate Dihydrate
19. Unii-02n1tzf99f
20. Tolectin Sdoium
21. Tolmetin Sodium [usan:usp:jan]
22. Tolectin (tn)
23. 1h-pyrrole-2-acetic Acid, 1-methyl-5-(4-methylbenzoyl)-, Sodium Salt,dihydrate
24. Tolmetin Sodium (jan/usp)
25. Tolmetin Sodium [jan]
26. Tolmetin Sodium [usan]
27. Tolmetin Sodium [vandf]
28. Chembl1437585
29. Dtxsid5045594
30. Tolmetin Sodium [mart.]
31. Tolmetin Sodium [usp-rs]
32. Hms1570l13
33. Hms2097l13
34. Hms3714l13
35. Bcp13056
36. Hy-b1489
37. Tox21_110792
38. Mfcd00150761
39. S4360
40. Tolmetin Sodium [orange Book]
41. Akos015901743
42. Tox21_110792_1
43. Ccg-220856
44. Ccg-267642
45. Cs-5160
46. Nsc 757341
47. Tolmetin Sodium [usp Monograph]
48. Ncgc00178815-03
49. Ac-31747
50. Tolmetin Sodium Salt Dihydrate [mi]
51. Ft-0649943
52. D00158
53. A834776
54. Q27139864
55. 1-methyl-5-(p-toluoyl)pyrrole-2-acetic Acid Sodium Salt, Dihydrate
56. Sodium [1-methyl-5-(4-methylbenzoyl)-1h-pyrrol-2-yl]acetate--water (1/2)
57. Sodium 2-[1-methyl-5-(4-methylphenyl)carbonyl-pyrrol-2-yl]ethanoate Dihydrate
58. Sodium 2-[1-methyl-5-[(4-methylphenyl)-oxomethyl]-2-pyrrolyl]acetate Dihydrate
59. 1h-pyrrole-2-acetic Acid, 1-methyl-5-(4-methylbenzoyl)-, Sodium Salt, Hydrate (1:1:2)
Molecular Weight | 315.30 g/mol |
---|---|
Molecular Formula | C15H18NNaO5 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 5 |
Rotatable Bond Count | 4 |
Exact Mass | 315.10826696 g/mol |
Monoisotopic Mass | 315.10826696 g/mol |
Topological Polar Surface Area | 64.1 Ų |
Heavy Atom Count | 22 |
Formal Charge | 0 |
Complexity | 353 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 4 |
Market Place
ABOUT THIS PAGE
65
PharmaCompass offers a list of Tolmetin Sodium Dihydrate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tolmetin Sodium Dihydrate manufacturer or Tolmetin Sodium Dihydrate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tolmetin Sodium Dihydrate manufacturer or Tolmetin Sodium Dihydrate supplier.
PharmaCompass also assists you with knowing the Tolmetin Sodium Dihydrate API Price utilized in the formulation of products. Tolmetin Sodium Dihydrate API Price is not always fixed or binding as the Tolmetin Sodium Dihydrate Price is obtained through a variety of data sources. The Tolmetin Sodium Dihydrate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 02N1TZF99F manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 02N1TZF99F, including repackagers and relabelers. The FDA regulates 02N1TZF99F manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 02N1TZF99F API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 02N1TZF99F supplier is an individual or a company that provides 02N1TZF99F active pharmaceutical ingredient (API) or 02N1TZF99F finished formulations upon request. The 02N1TZF99F suppliers may include 02N1TZF99F API manufacturers, exporters, distributors and traders.
02N1TZF99F Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 02N1TZF99F GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 02N1TZF99F GMP manufacturer or 02N1TZF99F GMP API supplier for your needs.
A 02N1TZF99F CoA (Certificate of Analysis) is a formal document that attests to 02N1TZF99F's compliance with 02N1TZF99F specifications and serves as a tool for batch-level quality control.
02N1TZF99F CoA mostly includes findings from lab analyses of a specific batch. For each 02N1TZF99F CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
02N1TZF99F may be tested according to a variety of international standards, such as European Pharmacopoeia (02N1TZF99F EP), 02N1TZF99F JP (Japanese Pharmacopeia) and the US Pharmacopoeia (02N1TZF99F USP).